These M2-like TAMs release anti-inflammatory cytokines, such as interleukin-10 (IL-10) and transforming growth factor-beta (TGF-β), which collectively contribute to the dampening of the immune response against cancer cells [37–40]. The gene discussed is IL10; the disease is cancer.